(Q37965770)

26 August 2017

title

Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile (English)

1 reference

26 August 2017

1 reference

2

F E R Simons

1 reference

26 August 2017

M A Calderón

1

1 reference

26 August 2017

H-J Malling

3

1 reference

26 August 2017

R F Lockey

4

1 reference

26 August 2017

P Moingeon

5

1 reference

26 August 2017

P Demoly

6

1 reference

26 August 2017

publication date

12 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

67

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

302-311

1 reference

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Systematic reviews of sublingual immunotherapy (SLIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Regulatory environment for allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Sublingual immunotherapy: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Patient's compliance with allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Immunological mechanisms of sublingual allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Sublingual immunotherapy and allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Allergy and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

The diagnosis and management of anaphylaxis practice parameter: 2010 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensiti

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02761.X

10.1111/J.1398-9995.2011.02761.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference